Shopping Cart
Remove All
Your shopping cart is currently empty
(RS)-Butyryltimolol, the racemate of Butyryltimolol, is an effective prodrug of Timolol that improves corneal penetration and acts as a β-adrenergic blocker [1][2].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $61 | 5 days | 5 days |
| Description | (RS)-Butyryltimolol, the racemate of Butyryltimolol, is an effective prodrug of Timolol that improves corneal penetration and acts as a β-adrenergic blocker [1][2]. |
| In vitro | Butyryltimolol is a prodrug of Timolol. Butyryltimolol is equally effective as 240-min nasolacrimal blockade in enhancing ocular drug absorption [1]. |
| Molecular Weight | 386.51 |
| Formula | C17H30N4O4S |
| Cas No. | 2320274-78-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (258.73 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 5 mg/mL (12.94 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.